Results 201 to 210 of about 129,026 (254)

Continuous Subcutaneous Versus Intestinal Levodopa Infusion for Parkinson's Disease: A Real‐World, Monocentric, Observational Study and Critical Review

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Subcutaneous foslevodopa‐foscarbidopa (SCFF) is a novel, non‐surgical dopaminergic infusion therapy for better controlling motor fluctuations in advanced Parkinson's disease (PD). However, there are scarce real‐world data on efficacy, adverse events and comparisons with other infusion strategies. Objectives Here, we aimed to provide
Johannes Hartig, Lennert Sitzmann, Doreen Hartenstein, Marion Labisch, Chi Wang Ip, Jens Volkmann, Christine Daniels   +6 more
wiley   +1 more source

Risk‐Benefit Considerations in Deep Brain Stimulation Discontinuation for Late‐Stage Parkinson's Disease

Movement Disorders Clinical Practice, EarlyView.
ABSTRACT Background Management of deep brain stimulation (DBS) in late‐stage Parkinson's disease (LSPD) remains challenging, particularly when deciding whether to continue or discontinue stimulation, and evidence on risk–benefit considerations is limited. Objectives To identify key factors to improve decision‐making in DBS management for LSPD patients.
Pietro Antenucci, Andrea Gozzi, Fabiana Colucci, Federica Pes, Jay Guido Capone, Alba Scerrati, Michele Alessandro Cavallo, Maura Pugliatti, Daniela Gragnaniello, Mariachiara Sensi   +9 more
wiley   +1 more source

Neuropsychiatric symptoms and progression to pathologically confirmed Alzheimer's disease. [PDF]

Brain
Sharif SF, Guan DX, Bodnar TS, Joseph JT, Zetterberg H, Smith EE, Ismail Z.   +6 more
europepmc   +1 more source

Coping Behavior in Patients with Parkinson's Disease Prior to Subthalamic Deep Brain Stimulation and Association with Psychiatric Symptoms, Quality of Life and Neuropsychological Status

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Coping behavior of Parkinson's disease (PD) patients undergoing subthalamic Deep Brain Stimulation (STN‐DBS) is poorly understood. Identifying patients with ineffective coping could help prepare them better for surgery. Objectives To clarify coping of PD patients preoperatively and the relation with psychiatric symptoms, quality of ...
Roy Brian Kuiper, Victor Jacobus Geraedts, Niels Anthony van der Gaag, Carel Frederik Ernst Hoffmann, Esther Lauwen, Rodi Zutt, Dirk Adrianus van der Zwart, Hubertus Anthonius Maria Middelkoop, Maria Fiorella Contarino   +8 more
wiley   +1 more source

The Hidden Burden of Hemifacial Spasm: A Systematic Review of Non‐Motor Symptoms

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Hemifacial spasm (HFS) is a chronic neurological disorder characterized by involuntary contractions of facial muscles. Traditionally regarded as a motor condition, HFS encompasses a spectrum of non‐motor symptoms that are often overlooked but significantly affect patients’ quality of life.
Miriam Carvalho Soares, Jacy Bezerra Parmera, Pedro Augusto Sampaio Rocha‐Filho   +2 more
wiley   +1 more source

Effect of tau burden and Lewy pathology on neuropsychiatric symptoms in Aβ-positive individuals. [PDF]

Alzheimers Dement
Kang S, Ye BS, Yun M, Lee YG, Alzheimer's Disease Neuroimaging Initiative.   +4 more
europepmc   +1 more source

Association between anosognosia and neuropsychiatric symptoms in Alzheimer's disease dementia patients. [PDF]

Sci Rep
Elnemais Fawzy M, Wang S, Palmer P, Gatchel J, Marshall GA, Gagliardi G, Vannini P, Alzheimer’s Disease Neuroimaging Initiative.   +7 more
europepmc   +1 more source